Paper35528971
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.
Kaya E and 1 other. J Clin Transl Hepatol, 2022. Cited by 165 papers, by iCite.
Cite this record
ConductScience Library. Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver. Papers, record 35528971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35528971
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References148
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26707365 | Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. | Hepatology | 2016 | https://conductscience.org/library/papers/26707365 | PubMed |
| 2 | 29150142 | Association between non-alcoholic fatty liver disease and cancer incidence rate. | J Hepatol | 2017 | https://conductscience.org/library/papers/29150142 | PubMed |
| 3 | 32696080 | NAFLD and cardiovascular diseases: a clinical review. | Clin Res Cardiol | 2021 | https://conductscience.org/library/papers/32696080 | PubMed |
| 4 | 32598051 | Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices. | Aliment Pharmacol Ther | 2020 | https://conductscience.org/library/papers/32598051 | PubMed |
| 5 | 25125077 | Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. | Hepatology | 2015 | https://conductscience.org/library/papers/25125077 | PubMed |
| 6 | 32059982 | NAFLD as a driver of chronic kidney disease. | J Hepatol | 2020 | https://conductscience.org/library/papers/32059982 | PubMed |
| 7 | 31098621 | The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance. | Endocr Rev | 2019 | https://conductscience.org/library/papers/31098621 | PubMed |
| 8 | 29935236 | Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis. | Metabolism | 2018 | https://conductscience.org/library/papers/29935236 | PubMed |
| 9 | 29286050 | Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. | Nat Rev Endocrinol | 2018 | https://conductscience.org/library/papers/29286050 | PubMed |
| 10 | 26791408 | The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women. | J Transl Med | 2016 | https://conductscience.org/library/papers/26791408 | PubMed |
| 11 | 31786360 | Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD. | Diabetes Metab | 2020 | https://conductscience.org/library/papers/31786360 | PubMed |
| 12 | 28674631 | Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure. | Open Heart | 2017 | https://conductscience.org/library/papers/28674631 | PubMed |
| 13 | 26636408 | Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals. | Eur J Gastroenterol Hepatol | 2016 | https://conductscience.org/library/papers/26636408 | PubMed |
| 14 | 31627243 | Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis. | Liver Int | 2020 | https://conductscience.org/library/papers/31627243 | PubMed |
| 15 | 31512278 | Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study. | J Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/31512278 | PubMed |
| 16 | 20369224 | Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. | Diabetologia | 2010 | https://conductscience.org/library/papers/20369224 | PubMed |
| 17 | 29122391 | Genetics and epigenetics of NAFLD and NASH: Clinical impact. | J Hepatol | 2018 | https://conductscience.org/library/papers/29122391 | PubMed |
| 18 | 22183820 | Prevalence of hypothyroidism in nonalcoholic fatty liver disease. | Dig Dis Sci | 2012 | https://conductscience.org/library/papers/22183820 | PubMed |
| 19 | 25386164 | Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments. | Front Endocrinol (Lausanne) | 2014 | https://conductscience.org/library/papers/25386164 | PubMed |
| 20 | 31470068 | The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study. | J Hepatol | 2019 | https://conductscience.org/library/papers/31470068 | PubMed |
Cited by130
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 165 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931549 | Eco-Environmental, Health and Socio-Economic Perspectives on Cyanobacteria and Cyanotoxins. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42931549 | PubMed |
| 42845096 | Metabolic Dysfunction-Associated Steatohepatitis and the Progression of Cognitive Decline in Older Thai People With HIV. | J Int AIDS Soc | 2026 | https://conductscience.org/library/papers/42845096 | PubMed |
| 42761919 | Drug Repurposing for Metabolic-Associated Fatty Liver Disease: Current Evidence, Challenges, and Future Perspectives. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42761919 | PubMed |
| 42737722 | From Molecular Mechanisms to Clinical Strategies: A Comprehensive Overview of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737722 | PubMed |
| 42718610 | Atherogenic index of plasma as a simple marker for NAFLD risk stratification in community-dwelling older adults: a cross-sectional study with incremental predictive value assessment. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42718610 | PubMed |
| 42701513 | Validation of voxel-based computed tomography liver fat quantification for assessing incident type 2 diabetes risk in a health check-up population. | Quant Imaging Med Surg | 2026 | https://conductscience.org/library/papers/42701513 | PubMed |
| 42649512 | Association between low skeletal muscle mass assessed by deep learning-based CT and MASLD: a prospective cohort study. | Diabetol Metab Syndr | 2026 | https://conductscience.org/library/papers/42649512 | PubMed |
| 42609490 | TASL practice guidance for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD). | Hepatol Forum | 2026 | https://conductscience.org/library/papers/42609490 | PubMed |
| 42602603 | Association of hepatic steatosis with MRI-defined renal steatosis in type 2 diabetes: a cross-sectional imaging and clinical modeling study. | Front Nutr | 2026 | https://conductscience.org/library/papers/42602603 | PubMed |
| 42559181 | ZRSR1 protects against obesity-associated hepatic lipogenesis independent of minor intron splicing. | Life Metab | 2026 | https://conductscience.org/library/papers/42559181 | PubMed |
| 42514401 | ZFP90 Serves as a Transcriptional Brake on NF-κB Signaling to Attenuate Diet-Induced MASLD Progression. | Nutrients | 2026 | https://conductscience.org/library/papers/42514401 | PubMed |
| 42483063 | Association between occupational noise exposure and metabolic dysfunction-associated fatty liver disease: the mediating role of body mass index in automotive manufacturing workers. | Front Public Health | 2026 | https://conductscience.org/library/papers/42483063 | PubMed |
| 42458273 | Development and validation of an online dynamic nomogram for nonobese metabolic dysfunction-associated steatotic liver disease based on body composition analysis. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42458273 | PubMed |
| 42373436 | [Construction norms for the tiered diagnosis and treatment and standardized management center of metabolic-associated fatty liver disease]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | https://conductscience.org/library/papers/42373436 | PubMed |
| 42290708 | Association of prediabetes phenotypes with metabolic dysfunction-associated fatty liver disease and liver fibrosis: a population-based study. | Ther Adv Endocrinol Metab | 2026 | https://conductscience.org/library/papers/42290708 | PubMed |
| 42120765 | The Liver-brain Axis: A Three-stage Model Linking MASLD to Cognitive Impairment and Dementia. | J Mol Neurosci | 2026 | https://conductscience.org/library/papers/42120765 | PubMed |
| 41889081 | Association between the Zhejiang University index and metabolic dysfunction-associated fatty liver disease as analyzed in National Health and Nutrition Examination Survey: A retrospective observational study. | J Int Med Res | 2026 | https://conductscience.org/library/papers/41889081 | PubMed |
| 41835374 | The relationship between triglyceride-glucose index, triglyceride-glucose-body mass index, and the severity of hepatic steatosis and liver fibrosis in patients with MASLD: a cross-sectional study. | Front Nutr | 2026 | https://conductscience.org/library/papers/41835374 | PubMed |
| 41810674 | NAFLD-related SNPs are linked to changes in liver fat, as measured by the CAP score, and serum lipids in response to a 3-week sugar-sweetened beverage intervention: a pilot study. | Food Funct | 2026 | https://conductscience.org/library/papers/41810674 | PubMed |
| 41792632 | The relationship between metabolic associated fatty liver disease and thyroid nodule: a cross-sectional study in China. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/41792632 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35528971
GET https://conductscience.org/api/papers/v1/35528971/references?page=2